NEW YORK, April 25, 2023 ‒ Aetion ®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce the culmination of the RCT-DUPLICATE demonstration project, with ...

The ARM architecture received a pleasant boost this year with the Cortex-A8 platform. Part of the new architecture adds the 16-bit Thumb-2EE instruction set that operates in the ThumbEE mode.

The What Works Clearinghouse (WWC) identifies studies that provide credible and reliable evidence of a given intervention’s effectiveness. Yet there is a high potential for serious estimation bias ...

Patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality, and there are virtually no therapeutic interventions besides dialysis treatment which are proven, in ...

Subjective cognition in chimeric antigen receptor T-cell therapy recipients. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.

CHICAGO – Loxo Oncology Inc.'s announcement that it will seek tissue-agnostic approval for larotrectinib (LOXO-101) based on data that were presented at this year's ASCO meeting came just weeks after ...

The clinical development plan is a blueprint that brings a new drug discovery from preclinical development to market approval. It helps to regulate the process of drug discovery, ensuring patient ...